MedBridge Shanghai · International medical facilitation platform recognized under Shanghai Government Document No. 32
MedBridge OncologyCancer Treatment in China
Back to home
Prof. Zhou Cai-Cun

Prof. Zhou Cai-Cun

Chief Physician · Professor · Director of Oncology

Shanghai Pulmonary Hospital, Tongji UniversityShanghai35 yrs Experience
Lung cancer

Academic Profile

Professor Zhou Caicun is Director of Oncology at Shanghai Pulmonary Hospital and of the Cancer Institute of Tongji University School of Medicine, and President-elect of the IASLC. His study series established immunotherapy in the first-line treatment of advanced lung cancer in China.

Phase III studies such as CAMEL and ORIENT were published in Lancet Respiratory Medicine and changed international practice; he is deeply accomplished in biomarker-guided individualized therapy.

Appointments & Honors

  • Board member of IASLC
  • Chair, CSCO NSCLC Expert Committee
  • Global PI of multiple phase III lung cancer immunotherapy trials

Appointments

  • Director, Oncology, Shanghai Pulmonary Hospital
  • President-elect, IASLC
  • Chair, CSCO NSCLC Committee

Areas of Expertise

  • Immunotherapy for advanced lung cancer
  • Lung cancer biomarker research
  • Individualized comprehensive lung cancer care

Academic Achievements

  • First President-elect of IASLC from mainland China
  • CAMEL, ORIENT and other studies changed first-line practice
  • National S&T Progress Award (2nd Class) recipient

Selected Publications

  • Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in advanced non-squamous NSCLC (CameL)

    The Lancet Respiratory Medicine · 2021

    First author

  • Bevacizumab plus paclitaxel/carboplatin as first-line treatment for advanced non-squamous NSCLC in China (BEYOND)

    Journal of Clinical Oncology · 2015

    First author

  • CSCO guidelines for the diagnosis and treatment of non-small cell lung cancer

    CSCO 指南工作委员会

    Editor-in-chief

View full publication list on PubMed

Cancer Focus

Lung Cancer · Immuno & Targeted Therapy

Outpatient Schedule

Tue AM · VIP Clinic
Thu AM · Lung Immunotherapy MDT

Schedules sync with the hospital’s official website daily at 00:00 CST. Actual availability is subject to the hospital’s same-day announcement.

Available Hospitals

Cancer Hospital, CAMS (National Cancer Center)

Beijing · Grade III-A · National Cancer Center

Sun Yat-sen University Cancer Center

Guangzhou · Grade III-A · Host of State Key Laboratory

Shanghai Proton and Heavy Ion Center

Shanghai · Grade III Specialty · National Particle Therapy Flagship

Related Specialists

Prof. He Jie, Academician

Thoracic Surgical Oncology (Lung / Esophageal)

Prof. Wu Yi-Long

Precision Lung Cancer Care

Prof. Wang Jie

Thoracic Medical Oncology (Lung Cancer)

Prof. Zhi Xiu-Yi

Thoracic Surgery · Early Lung Cancer

CASE FEASIBILITY REVIEW

Submit Your Case for a Free Review

Share your contact details, confirmed diagnosis and main question. No medical files needed at this stage. A clinical coordinator will contact you within 24-48 hours.

  • No medical file upload required at this stage
  • By submitting you agree to our privacy policy. Your information is used solely for hospital assessment and transmitted encrypted.